首页> 美国卫生研究院文献>Stem Cells International >An Osteoconductive Osteoinductive and Osteogenic Tissue-Engineered Product for Trauma and Orthopaedic Surgery: How Far Are We?
【2h】

An Osteoconductive Osteoinductive and Osteogenic Tissue-Engineered Product for Trauma and Orthopaedic Surgery: How Far Are We?

机译:用于创伤和骨科手术的骨传导骨诱导和成骨组织工程产品:我们走了多远?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The management of large bone defects due to trauma, degenerative disease, congenital deformities, and tumor resection remains a complex issue for the orthopaedic reconstructive surgeons. The requirement is for an ideal bone replacement which is osteoconductive, osteoinductive, and osteogenic. Autologous bone grafts are still considered the gold standard for reconstruction of bone defects, but donor site morbidity and size limitations are major concern. The use of bioartificial bone tissues may help to overcome these problems. The reconstruction of large volume defects remains a challenge despite the success of reconstruction of small-to-moderate-sized bone defects using engineered bone tissues. The aim of this paper is to understand the principles of tissue engineering of bone and its clinical applications in reconstructive surgery.
机译:由于创伤,退行性疾病,先天性畸形和肿瘤切除而导致的大骨缺损的管理仍然是整形外科外科医生的复杂问题。要求是理想的骨替代物,其具有骨传导性,骨诱导性和成骨性。自体骨移植物仍被认为是重建骨缺损的金标准,但供体部位的发病率和大小限制是主要关注的问题。生物人工骨组织的使用可能有助于克服这些问题。尽管使用工程骨组织成功重建了中小尺寸的骨缺损,但重建大体积缺损仍然是一个挑战。本文的目的是了解骨组织工程的原理及其在重建手术中的临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号